Drugs / 17β-Oestradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01153581 | Feb 2006 → Dec 2012 | — | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17β-Oestradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153581 ↗ |
| Route | Other | “0.2 mg day-1 patch (Vivelle; CIBA Pharmaceuticals, Summit, NJ)” NCT01153581 ↗ |